Search Results 891-900 of 18577 for Relapse
... relapse (Phase I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) ...
However, he says patients who relapse are often successfully treated with additional treatments so previous comparative studies of other drug combinations ...
Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Featured News. Mayo Clinic researchers link CAR-T cell aging to cancer relapse.
Both newly diagnosed and relapsed refractory patients with AML will be assigned to different cohorts based on specific study criteria and physician discretion.
... relapsed/refractory multiple myeloma (RRMM). Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2 ...
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Eau Claire, Wis., Mankato, Minn., La Crosse, Wis., ...
This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory ...
This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT ( ...
"But most of those patients relapsed within two years, as the CAR-T cells ... Kenderian's, was designed to address relapse. Previous clinical trials ...
... relapsed Acute myelogenous leukemia (AML) and other selected B-cell ... First Relapse and primary induction failure in AML (M3 excluded); Secondary ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.